LORI LEONARD: Open Payments
NPI 1811314644 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 41 payments from 7 companies in 2025. Trend: 2023 $999 · 2024 $448 · 2025 $791
Food & beverage: $791
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $289 |
| Otsuka America Pharmaceutical, Inc. | 11 | $197 |
| Axsome Therapeutics, Inc. | 3 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $104 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Alkermes, Inc. | 1 | $16 |
Products named: VRAYLAR, REXULTI, Auvelity, CAPLYTA, AUSTEDO XR, TRINTELLIX, ARISTADA.
Industry payments across GA — which companies pay providers there.
